Crown (CCK) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
6 Jan, 2026Executive summary
Q1 2025 diluted EPS was $1.65, up from $0.56; adjusted EPS reached $1.67, with net income rising to $193 million from $67 million year-over-year.
Net sales increased to $2,887 million, driven by higher beverage can volumes in the Americas and Europe, and improved manufacturing performance.
Segment income rose 29% to $398 million, led by strong Americas and Europe beverage performance, while Transit Packaging declined.
EBITDA for the trailing 12 months surpassed $2 billion for the first time, with EBITDA margins up 260 basis points.
Over $200 million was returned to shareholders in Q1, mainly through share repurchases.
Financial highlights
Net sales grew by $103 million year-over-year, primarily from higher material costs and beverage can volumes.
Operating income increased to $365 million from $245 million year-over-year.
Adjusted segment income for reportable segments was $410 million, up from $350 million year-over-year.
Cash and cash equivalents at quarter-end were $779 million, with $650 million held outside the U.S.
Adjusted EBITDA for the trailing twelve months exceeded $2 billion, $90 million higher than 2024.
Outlook and guidance
Full-year adjusted EPS guidance raised to $6.70–$7.10; Q2 EPS projected at $1.80–$1.90.
Full-year adjusted free cash flow estimated at $800 million after $450 million in capital spending.
Net interest expense expected at $360 million; non-controlling interest expense at $160 million.
Net leverage targeted at 2.5x by year-end 2025.
Management does not expect the OECD Pillar II global minimum tax to materially impact 2025 results.
Latest events from Crown
- Board recommends director elections, auditor ratification, pay approval, and opposes written consent.CCK
Proxy filing23 Mar 2026 - Record EBITDA, strong cash flow, and improved leverage drive positive 2026 outlook.CCK
Q4 20255 Feb 2026 - Strong global beverage can growth, higher earnings, and a $2B buyback program announced.CCK
Q2 20243 Feb 2026 - Strong beverage can growth and higher income offset by pension settlement charges.CCK
Q3 202419 Jan 2026 - Record EBITDA, strong cash flow, and reduced leverage highlight a positive 2025 outlook.CCK
Q4 20248 Jan 2026 - Board backs director elections, auditor, and pay, but opposes political spending disclosure proposal.CCK
Proxy Filing1 Dec 2025 - Q2 adjusted EPS up 19%, sales and cash flow strong, and guidance raised for the year.CCK
Q2 20254 Nov 2025 - Q3 2025 delivered higher sales, strong European growth, and raised guidance with robust shareholder returns.CCK
Q3 202530 Oct 2025